The fact
Conducted in double-blind with 600 adults, the treatment targets obesity and diabetes.
Results may change therapeutic protocols by 2026.
2 sources — click a link to read an article on the topic:
Conducted in double-blind with 600 adults, the treatment targets obesity and diabetes.
Results may change therapeutic protocols by 2026.